fluidIQ

fluidIQ is an early-stage medical device company leveraging proprietary fluidics technology to develop non-electric, low-cost emergency resuscitation and ventilation devices. Its lead product, the HOPE inVent, is a handheld, automatic resuscitator designed for EMS and first responders, pending FDA De Novo clearance. Founded by a multidisciplinary team of doctors, engineers, and advocates during the COVID-19 pandemic, the company aims to disrupt the emergency medicine market with robust, globally manufacturable solutions that provide lung-protective ventilation.

Proprietary fluidics platform using flows and pressures of fluids/air to control device operations without electricity, batteries, or moving parts. Enables solid-state, robust, and low-cost medical devices.

fluidIQ competes in the emergency resuscitation market against large incumbents like Ambu, Medtronic, and Vyaire, which sell traditional manual resuscitators and more complex transport ventilators. Its key differentiation is the combination of automatic, lung-protective ventilation in a simple, non-electric device. It may face competition from other startups developing portable ventilators, but few leverage a pure fluidics approach, potentially giving fluidIQ a unique cost and robustness advantage.